Endometriosis markers: Immunologic alterations as diagnostic indicators for endometriosis

Reproductive Sciences

Volumn 14, Issue 6, 2007, Pages 595-604

  Bohler, Henry C ^a   Gercel Taylor, Cicek ^a   Lessey, Bruce A ^b   Taylor, Douglas D ^a  

^a University of Louisville School of Medicine   (United States)

^b GREENVILLE HOSPITAL SYSTEM   (United States)

Author keywords

Autoantibodies; Diagnosis; Endometriosis

Indexed keywords

AUTOANTIBODY; CELL ANTIGEN; CELL PROTEIN; GAMMA INTERFERON; MEMBRANE PROTEIN; BIOLOGICAL MARKER; SIGNAL PEPTIDE;

ADULT; ARTICLE; CONTROLLED STUDY; ENDOMETRIOSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING; BIOSYNTHESIS; BLOOD; CASE CONTROL STUDY; DOWN REGULATION; HOSPITALIZATION; IMMUNOLOGY; METABOLISM; PREDICTION AND FORECASTING; TUMOR CELL LINE;

ADULT; AUTOANTIBODIES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CELL LINE, TUMOR; DOWN-REGULATION; ENDOMETRIOSIS; FEMALE; HUMANS; INTERFERON TYPE II; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KILLER CELLS, NATURAL; MEMBRANE PROTEINS; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX;

EID: 38449119442     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719107307910     Document Type: Article

References (47)

1. Gao X., Outley J., Botteman M., Spalding J., Simon JA, Pashos CL Economic burden of endometriosis. Fertil Steril. 2006 ; 86: 1561-1572.
2. Missmer SA, Cramer DW The epidemiology of endometriosis. Obstet Gynecol Clin North Am. 2003 ; 30: 1-19.
3. Schindler AE Pathophysiology, diagnosis and treatment of endometriosis. Minerva Ginecol. 2004 ; 56: 419-435.
4. Guo SW, Wang Y. Sources of heterogeneities in estimating the prevalence of endometriosis in infertile and previously fertile women. Fert Steril. 2006 ; 86: 1584-1595.
5. Gerety E., Harris RD Endometriosis: epidemiology, current pathophysiological concepts, and imaging considerations. Appl Radiol. 2001 ; 30: 11-18.
6. Valle RF, Sciarra JJ Endometriosis: treatment strategies. Ann N Y Acad Sci. 2003 ; 997: 229-239.
7. Berube S., Marcoux S., Maheux R., et al. Characteristics related to the prevalence of minimal or mild endometriosis in infertile women. Epidemiology. 1998 ; 9: 505-510.
8. Vigano P., Parazzini F., Somigliana E., Vercellini P. Endometriosis: epidemiology and aetiological factors. Best Pract Res Clin Obstet Gynaecol. 2004 ; 18: 177-200.
9. Gazvani R., Templeton A. Peritoneal environment, cytokines and angiogenesis in the pathophysiology of endometriosis. Reproduction. 2002 ; 123: 217-226.
10. Fowler PA, Tattum J., Bhattacharya S., et al. An investigation of the effects of endometriosis on the proteome of human eutopic endometrium: a heterogeneous tissue with a complex disease. Proteomics. 2007 ; 7: 130-142.
11. Wenzl R., Kiesel L., Huber JC, Wieser F. Endometriosis: a genetic disease. Drugs Today. 2003 ; 39: 961-972.
12. Wieser F., Hefler L., Tempfer C., et al. Polymorphism of the interleukin-1beta gene and endometriosis. J Soc Gynecol Investig. 2003 ; 10: 172-175.
13. Seli E., Arici A. Endometriosis: interaction of immune and endocrine systems. Semin Reprod Med. 2003 ; 21: 135-144.
14. Kennedy S., Bergqvist A., Chapron C., et al. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod. 2005 ; 20: 2698-2704.
15. Ballard K., Lowton K., Wright JT What's the delay? A qualitative study of women's experience of reaching a diagnosis of endometriosis. Fertil Steril. 2006 ; 85: 1296-1301.
16. Donnez J., Squifflet J., Casanas-Roux F., Pirard C., Jadoul P., Van Langendonckt A. Typical and subtle atypical presentations of endometriosis. Obstet Gynecol Clin North Am. 2003 ; 30: 83-93.
17. Chang WC, Li TC, Lin CC The effect of physician experience on costs and clinical outcomes of laparoscopic-assisted vaginal hysterectomy: a multivariate analysis. J Am Assoc Gynecol Laparosc. 2003 ; 10: 356-359.
18. Eskenazi B., Warner M., Bosignore L., Olive D., Samuels P., Vercellini S. Validation study of nonsurgical diagnosis of endometriosis. Fertil Steril. 2001 ; 76: 929-935.
19. Kinkel K., Brosens J., Brosens I. Preoperative investigations. In: Sutton C, Jones K, Adamson D, eds. Modern Management of Endometriosis. Basingstoke, UK: Taylor & Francis; 2006: 71-85.
20. Winkel CA Evaluation and management of women with endometriosis. Obstet Gynecol. 2003 ; 102: 397-408.
21. Mol BW, Bayram N., Lijmer JG, et al. The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis. Fertil Steril. 1998 ; 70: 1101-1108.
22. Rier SE, Yeaman GR Immune aspects of endometriosis: relevance of the uterine mucosal immune system. Semin Reprod Endocrinol. 1997 ; 15: 209-220.
23. Lebovic DI, Mueller MD, Taylor RN Immunobiology of endometriosis. Fertil Steril. 2001 ; 75: 1-10.
24. Nothnicik WB Treating endometriosis as an autoimmune disease. Fertil Steril. 2001 ; 76: 223-240.
25. Oosterlynck DJ, Cornillie FJ, Waer M., Vandeputte M., Koninckx PR Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium. Fertil Steril. 1991 ; 56: 45-51.
26. Siristatidis C., Nissotakis C., Chrelias C., Iacovidou H., Salamalekis E. Immunological factors and their role in the genesis and development of endometriosis. J Obstet Gynaeol Res. 2006 ; 32: 162-170.
27. Seery JP Endometriosis associated with defective handling of apoptotic cells in the female genital tract is a major cause of autoimmune disease in women. Med Hypothesis. 2006 ; 66: 945-949.
28. Salamonsen LA, Lathbury LJ Endometrial leukocytes and menstruation. Hum Reprod Update. 2000 ; 6: 16-27.
29. Wilson TJ, Hertzog PJ, Angus D., Munnery L., Wood EC, Kola I. Decreased natural killer cell activity in endometriosis patients: relationship to disease pathogenesis. Fertil Steril. 1994 ; 62: 1086-1088.
30. Ho HN, Chao KH, Chen HF, Wu MY, Yang YS, Lee TY Peritoneal natural killer cytotoxicity and CD25+ CD3+ lymphocyte subpopulation are decreased in women with stage III-IV endometriosis. Hum Reprod. 1995 ; 10: 2671-2675.
31. Yeaman GR, Collins JE, Lang GA Autoantibody responses to carbohydrate epitopes in endometriosis. Ann N Y Acad Sci. 2002 ; 955: 174-184.
32. Bedaiwy MA, Falcone T. Laboratory testing for endometriosis. Clin Chim Acta. 2004 ; 340: 41-56.
33. Iborra A., Palacio JR, Martinez P. Oxidative stress and autoimmune response in the infertile woman. Chem Immunol Allergy. 2005 ; 88: 150-162.
34. Shanti A., Santanam N., Morales AJ, Parthasarathy S., Murphy AA Autoantibodies to markers of oxidative stress are elevated in women with endometriosis. Fertil Steril. 1999 ; 71: 1115-1118.
35. Forges T., Monnier-Barbarino P., Faure GC, Bene MC Autoimmunity and antigenic targets in ovarian pathology. Hum Reprod Update. 2004 ; 10: 163-175.
36. Erkanli A., Taylor DD, Dean D., et al. Application of Bayesian modeling of autologous antibody responses against ovarian tumor-associated antigens to cancer detection. Cancer Res. 2006 ; 66: 1792-1798.
37. Eblen AC, Gercel-Taylor C., Shields Lbe, Sanfillipo JS, Nakajima ST, Taylor DD Alterations in humoral immune responses associated with recurrent pregnancy loss. Fertil Steril. 2000 ; 73: 305-313.
38. Laemmli UK Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 ; 227: 680-685.
39. Brown R., Clugston C., Burns P., et al. Increased accumulation of p53 protein in cisplatin-resistant ovarian cell lines. Int J Cancer. 1993 ; 55: 678-684.
40. Gong JH, Maki G., Klingemann HG Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells. Leukemia. 1994 ; 8: 652-658.
41. Taylor DD, Gercel-Taylor C. Alterations in T-cell signal transduction molecules associated with recurrent spontaneous pregnancy loss. J Reprod Immunol. 2004 ; 63: 137-154.
42. Mathur S., Peress MR, Williamson HO, et al. Autoimmunity to endometrium and ovary in endometriosis. Clin Exp Immunol. 1982 ; 50: 259-266.
43. Gleicher N., Adelsberg BR, Liu TL, Cederqvist LL, Phillips RL, Siegel I. Immune complexes in pregnancy: III. Immune complexes in immune complex-associated conditions. Am J Obstet Gynecol. 1982 ; 142: 1011-1015.
44. Kiechle FL, Quattrociocchi-Longe TM, Brinton DA Carbonic anhydrase antibody in sera from patients with endometriosis. Am J Clin Pathol. 1994 ; 101: 611-615.
45. Pillai S., Zhou GX, Arnaud P., Jiang H., Butler WJ, Zhang H. Antibodies to endometrial transferring and alpha 2-Heremans Schmidt (HS) glycoprotein in patients with endometriosis. Am J Reprod Immunol. 1996 ; 35: 483-494.
46. Taylor PV, Maloney MD, Campbell Skerrow SM, et al. A utoreactivity in women with endometriosis. Br J Obstet Gynaecol. 1991 ; 98: 680-684.
47. Kanzaki H., Wang HS, Kariya M., Mori T. Suppression of natural killer cell activity by sera from patients with endometriosis. Am J Obstet Gynecol. 1992 ; 167: 257-261.